Exploiting cancer cells' weaknesses
Team identifies potential drugs that enhance stress caused by too many chromosomes.
Team identifies potential drugs that enhance stress caused by too many chromosomes.
New MIT nanoparticles could lead to powerful vaccines for HIV and other diseases.
New implantable sensor finds telltale signs; technology could also be adapted to monitor cancer and other diseases.
Blood-vessel cells can combat aggressive tumors, helping to prevent them from spreading through the body, new study finds.
The new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.
Implanted device can release slow, steady dose of medicine over extended period, removing the need for repeated procedures.
Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.
Completion of cancer-research building opens green space for community use and creates vibrant streetscape.
Cancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
RNA interference holds much promise as a cancer treatment, but technical challenges remain.
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
Shutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.
MIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.